LRRK2 and gastric cancer: Because of the absence of clonal mutations classified as likely pathogenic, nine genes (TG, WRN, PLCG1, LAMA5, RTEL1, FASN, CDK12, LRRK2, and MACF1), were considered unlikely to be candidate gastric cancer drivers.